Could a probiotic pill help kids with PKU?

NCT ID NCT05948020

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an engineered probiotic called CBT102-A in 15 children with phenylketonuria (PKU), a condition where the body cannot break down an amino acid called phenylalanine. The children took the probiotic or a placebo for 20 days. The goal was to see if the probiotic could safely lower blood phenylalanine levels, potentially easing the need for a strict diet.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

engineered probiotic (CBT102-A)

What this could lead to

If it works, this could offer a new way to manage PKU by helping the body break down phenylalanine without a strict diet.

What could go wrong

This is a very early, small trial (15 children) testing safety and short-term effects. The probiotic may not lower phenylalanine enough or could cause side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PHENYLKETONURIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

phenylketonuria

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Children's Hospital of Fudan University

    Shanghai, China